Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX3305 in Active Rheumatoid Arthritis
NCT00903383Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jul 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of lx3305 in rheumatoid arthritis (RA), sponsored by Lexicon Pharmaceuticals, Inc.. Started Jul 2009; status: completed.
02
Drugs
lx3305
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00903383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903383.